Envista (NYSE:NVST) Upgraded by JPMorgan Chase & Co. to Overweight Rating

Envista (NYSE:NVST) was upgraded by JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued on Thursday, Briefing.com reports. The brokerage presently has a $32.00 target price on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 16.95% from the company’s current price.

Several other analysts have also recently issued reports on the stock. Robert W. Baird set a $34.00 target price on shares of Envista in a research note on Thursday, August 6th. Morgan Stanley set a $23.00 price target on shares of Envista in a research report on Thursday, August 6th. Zacks Research raised shares of Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. BMO Capital Markets began coverage on Envista in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price objective on the stock. Finally, Evercore reissued an “outperform” rating and set a $33.00 price objective on shares of Envista in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.71.

Envista Stock Up 2.7%

Shares of NYSE NVST opened at $27.36 on Thursday. Envista has a 52 week low of $18.77 and a 52 week high of $30.42. The business has a 50-day simple moving average of $27.20 and a two-hundred day simple moving average of $26.30. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47. The company has a market cap of $4.39 billion, a P/E ratio of 47.17, a P/E/G ratio of 1.27 and a beta of 0.86.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The firm had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same period in the prior year, the business posted $0.26 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Research analysts anticipate that Envista will post 1.53 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president directly owned 27,321 shares of the company’s stock, valued at $751,327.50. This trade represents a 22.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Envista

A number of institutional investors have recently made changes to their positions in the stock. California State Teachers Retirement System lifted its holdings in shares of Envista by 2,460.3% during the 2nd quarter. California State Teachers Retirement System now owns 4,972,429 shares of the company’s stock worth $131,024,000 after acquiring an additional 4,778,217 shares during the last quarter. Millennium Management LLC raised its position in Envista by 1,442.7% during the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock valued at $52,552,000 after purchasing an additional 2,263,712 shares in the last quarter. Holocene Advisors LP purchased a new stake in Envista during the second quarter valued at about $43,936,000. Arrowstreet Capital Limited Partnership lifted its stake in Envista by 341.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after purchasing an additional 2,210,847 shares during the last quarter. Finally, Norges Bank bought a new stake in Envista during the fourth quarter worth about $45,113,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.